Astellas Pharma Competitors and Similar CompaniesClear all

Astellas Pharma's competitors and similar companies include Bayer, Immunomedics, Urovant Sciences, Hetero and Viatris.

	Astellas Pharma Astellas Pharma (アステラス製薬株式会社) is a pharmaceutical company focused on the development of drugs and medical solutions.	Bayer Bayer is a life sciences company specializing in healthcare and nutrition.	Immunomedics Immunomedics is a developer of monoclonal antibody-based products for the targeted treatment of cancer.	Urovant Sciences Urovant Sciences is a biopharmaceutical company focused on developing novel therapies for urologic conditions.	Hetero Hetero is a generic pharmaceutical company engaged in the development, manufacturing, and marketing of chemical and biologic drugs.	Viatris Viatris is a pharmaceutical company that develops and manufactures branded and generic medicines, biosimilar medicines, and over-the-counter products.
Founding Date	Founding Date 1923	Founding Date 1863	Founding Date 1982	Founding Date 2016	Founding Date 1993	Founding Date 2020
Type	Type Public	Type Public	Type Subsidiary	Type Subsidiary	Type Private	Type Public
Tags	Tags Healthcare diabetes drug development oncology pharma	Tags Healthcare Manufacturing & Industrial agritech biotech conglomerates drug development life sciences nutrition pharma	Tags Healthcare biotech oncology pharma	Tags Healthcare biotech pharma therapy	Tags Manufacturing & Industrial biotech drug development pharma	Tags Healthcare biotech diabetes oncology pharma
Locations	Locations Tokyo, JP HQ Macquarie Park, AU Wien, AT Vilvoorde, BE São Paulo, BR Markham, CA Beijing, CN see more	Locations Leverkusen, DE HQ Tirana, AL Dely Ibrahim, DZ Luanda, AO Munro, AR Pymble, AU Wien, AT see more	Locations Morris Plains, US HQ	Locations Irvine, US HQ Basel, CH	Locations Hyderabad, IN HQ Norwest, AU Sao Paulo, BR Beijing, CN Nanjing Shi, CN Nanjing Shi, CN Bogotá, CO see more	Locations Canonsburg, US HQ Carole Park, AU Millers Point, AU Campos Dos Goytacazes, BR São Paulo, BR Sofia, BG Toronto, CA see more
Employees	Employees 14,754	Employees 94,2454% decrease	Employees 1051% increase	Employees 3950% increase	Employees 6,4132% increase	Employees 38,0003% increase
Valuation ($)	Valuation ($) 20.8 b	Valuation ($) 27.1 b	Valuation ($) N/A	Valuation ($) N/A	Valuation ($) N/A	Valuation ($) 14 b
Financial
Revenue (est.)	Revenue (est.) ¥1.6t (FY, 2024)	Revenue (est.) €47.6b (FY, 2023)	Revenue (est.) $295k (FY, 2019)	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) $14.7b (FY, 2024)
Cost of goods	Cost of goods ¥134.6b (FY, 2024)	Cost of goods €7b (FY, 2023)	Cost of goods N/A	Cost of goods N/A	Cost of goods N/A	Cost of goods $9.1b (FY, 2024)
Gross profit	Gross profit ¥1.5t (FY, 2024)	Gross profit €42.1b (FY, 2023)	Gross profit $295k (FY, 2019)	Gross profit N/A	Gross profit N/A	Gross profit $5.6b (FY, 2024)
Net income	Net income ¥17b (FY, 2024)	Net income (€2.9b) (FY, 2023)	Net income ($357.3m) (FY, 2019)	Net income ($146.7m) (FY, 2020)	Net income N/A	Net income ($634.2m) (FY, 2024)
Operating ⚠
Countries	Countries N/A	Countries 83 (FY, 2021)	Countries N/A	Countries N/A	Countries 126 (Jan, 2021)	Countries 165 (Q1, 2023)
Patent Applications (US)	Patent Applications (US) N/A	Patent Applications (US) N/A	Patent Applications (US) 230 (Sep, 2022)	Patent Applications (US) N/A	Patent Applications (US) 23 (Jan, 2021)	Patent Applications (US) N/A
Patents (US)	Patents (US) N/A	Patents (US) N/A	Patents (US) 405 (Sep, 2022)	Patents (US) N/A	Patents (US) 38 (Jan, 2021)	Patents (US) N/A
Products	Products N/A	Products N/A	Products N/A	Products N/A	Products 200 (Jan, 2021)	Products 4 (FY, 2022)
Funding
Total funding raised	Total funding raised N/A	Total funding raised $ 3.5b	Total funding raised $ 30m	Total funding raised N/A	Total funding raised N/A	Total funding raised N/A